Literature DB >> 10891410

Impaired entry of soluble receptor-resistant mutants of mouse hepatitis virus into cells expressing MHVR2 receptor.

S Matsuyama1, F Taguchi.   

Abstract

Mouse hepatitis virus (MHV) JHMV and its soluble receptor-resistant (srr) mutants, srr7, srr11, and srr18, grew and induced syncytia equally well in BHK-R1 cells expressing the MHVR1 receptor derived from MHV-susceptible BALB/c mice. In contrast, srr growth and syncytia formations were drastically reduced relative to wild-type (wt) virus in BHK-R2 cells expressing the MHVR2 receptor from MHV-resistant SJL mice. Infections by these srr mutants in BHK-R2 cells were 0.7 to 1.5 log10 less efficient than those of wt virus. BHK cells expressing both MHVR1 and MHVR2 supported srr replication to the same extent as did BHK-R1 cells, suggesting that inefficient infection by srr mutants in BHK-R2 cells resulted from the absence of the effective receptor MHVR1. Virus-receptor binding tests failed to demonstrate a difference between the abilities of wt and srr18 to bind MHVR2. The binding of srr7 and srr11 to both MHVR1 and MHVR2 was revealed lower by two- to fourfold relative to the wt binding. The fusion activity of srr S proteins as examined by the expression with recombinant vaccinia virus was apparently lower than that of the wt S protein in BHK-R2 cells, while there was not such a remarkable difference in BHK-R1 cells. This suggests that the most likely reason for inefficient infection by mutants in BHK-R2 is impaired virus entry into cells. These observations suggest that inefficient infections in BHK-R2 cells by srr mutants occur in the absence of a functional receptor MHVR1, which plays an important role in srr entry into cells. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10891410     DOI: 10.1006/viro.2000.0409

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  16 in total

1.  Protease-mediated enhancement of severe acute respiratory syndrome coronavirus infection.

Authors:  Shutoku Matsuyama; Makoto Ujike; Shigeru Morikawa; Masato Tashiro; Fumihiro Taguchi
Journal:  Proc Natl Acad Sci U S A       Date:  2005-08-22       Impact factor: 11.205

2.  Receptor-induced conformational changes of murine coronavirus spike protein.

Authors:  Shutoku Matsuyama; Fumihiro Taguchi
Journal:  J Virol       Date:  2002-12       Impact factor: 5.103

3.  Receptor-independent infection of murine coronavirus: analysis by spinoculation.

Authors:  Rie Watanabe; Shutoku Matsuyama; Fumihiro Taguchi
Journal:  J Virol       Date:  2006-05       Impact factor: 5.103

4.  Enhancement of SARS-CoV infection by proteases.

Authors:  Shutoku Matsuyama; Makoto Ujike; Koji Ishii; Shuetsu Fukushi; Shigeru Morikawa; Masato Tashiro; Fumihiro Taguchi
Journal:  Adv Exp Med Biol       Date:  2006       Impact factor: 2.622

5.  Soluble receptor potentiates receptor-independent infection by murine coronavirus.

Authors:  Fumihiro Taguchi; Shutoku Matsuyama
Journal:  J Virol       Date:  2002-02       Impact factor: 5.103

6.  N-terminal domain of the murine coronavirus receptor CEACAM1 is responsible for fusogenic activation and conformational changes of the spike protein.

Authors:  Hideka S Miura; Keiko Nakagaki; Fumihiro Taguchi
Journal:  J Virol       Date:  2004-01       Impact factor: 5.103

7.  Mutations conferring resistance to neutralization by a soluble form of the neurotrophin receptor (p75NTR) map outside of the known antigenic sites of the rabies virus glycoprotein.

Authors:  Christelle Langevin; Christine Tuffereau
Journal:  J Virol       Date:  2002-11       Impact factor: 5.103

8.  Protease-mediated entry via the endosome of human coronavirus 229E.

Authors:  Miyuki Kawase; Kazuya Shirato; Shutoku Matsuyama; Fumihiro Taguchi
Journal:  J Virol       Date:  2008-10-29       Impact factor: 5.103

9.  The N-terminal domain of the murine coronavirus spike glycoprotein determines the CEACAM1 receptor specificity of the virus strain.

Authors:  Jean C Tsai; Bruce D Zelus; Kathryn V Holmes; Susan R Weiss
Journal:  J Virol       Date:  2003-01       Impact factor: 5.103

10.  Pathogenesis of neurotropic murine coronavirus is multifactorial.

Authors:  Judith M Phillips; Susan R Weiss
Journal:  Trends Pharmacol Sci       Date:  2010-12-07       Impact factor: 14.819

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.